Emergers Feed

2025-12-12 08:00:00 Equity Research | NANEXA: First license with Moderna an important validation of PharmaShell

2025-11-14 08:00:00 Equity Research | CRUNCHFISH: Breakthrough integration sets stage for commercial expansion

2025-11-07 08:00:00 Equity Research | NANEXA: Intensified focus on deals amid growing funding pressure

2025-09-25 08:00:00 Video | CRUNCHFISH: Lunchsnack om ny finansiering, affärs- och marknadstrategi samt nytt pilotavtal

2025-09-22 11:45:00 Inbjudan till lunchsnack med CRUNCHFISH vd Joachim Samuelsson onsd 24 september kl 12:00-13:00

2025-08-29 08:00:00 Equity Research | PROLIGHT: Financing and partner interest strengthen case ahead of regulatory study

2025-08-28 08:00:00 Equity Research | NANEXA AB: Positive clinical data balanced by strategic uncertainty about NEX-22 roadmap

2025-08-25 15:00:00 Video | CRUNCHFISH: Lunchsnack om halvårsrapporten med VD Joachim Samuelsson

2025-08-25 08:00:00 Equtiy Research | CRUNCHFISH: Improved outlook with NPCI adoption and global validation + Lunchsnack (in SWE)

2025-08-11 16:00:00 Video | CRUNCHFISH: Lunchsnack med vd Joachim Samuelsson om bolagets strategi och marknadsutvecklingen

2025-08-08 10:00:00 Inbjudan till lunchsnack med CRUNCHFISH vd Joachim Samuelsson månd 11 augusti kl 12:00-13:00

2025-07-03 08:00:00 Equity Research | PROLIGHT: Fully subscribed rights issue strengthens Psyros case ahead of commercial partnerships

2025-06-18 08:00:00 Equity Research | PROLIGHT: Positive patient data and patent approval strengthen case for Psyros

2025-06-12 08:00:00 VIDEO: Lunchsnack med CRUNCHFISH vd Joachim Samuelsson om Rethinking Payments

2025-06-10 08:00:00 Välkommen på lunchsnack med CRUNCHFISH vd Joachim Samuelsson onsdag 11 juni kl 12:00-13:00

2025-05-26 08:00:00 Video | CRUNCHFISH: Lunchsnack med vd Joachim Samuelsson om nya approachen till Offline Payments

2025-05-26 08:00:00 Equity Research | CRUNCHFISH: Third time a charm? New offline strategy targets system integration

2025-05-23 08:00:00 Equity Research | Prolight Diagnostics AB: Gearing up for commercialisation with strong insider backing

2025-05-22 10:00:00 Välkommen på lunchsnack med CRUNCHFISH vd Joachim Samuelsson fredag 23 maj kl 12:00-13:00

2025-05-07 08:00:00 Equity Research | NANEXA: Clinical milestones align ahead of phase Ib/II and licensing push

2025-04-17 08:00:00 Video från lunchseminarium med CRUNCHFISH vd Joachim Samuelsson

2025-04-14 08:00:00 Välkommen på lunchseminarium med CRUNCHFISH vd Joachim Samuelsson onsdag 16 april kl 12:00-13:00

2025-04-01 08:00:00 Equity Research | PROLIGHT: Positive results from the pre-clinical validation study de-risk the full clinical validation

2025-03-06 09:50:00 Equity Research | TALLINK: Free cash flow support dividends

2025-02-20 08:00:00 Equity Research | Nanexa AB: Targeting treatment of first patient in phase Ib/II with NEX-22 before year-end

2025-02-14 08:00:00 Equity Research | Crunchfish: Still in the running for a one billion-user Digital Cash market

2025-01-27 08:00:00 Equity Research | NANEXA: Financing secured into 2026 to drive NEX-22 development

2025-01-24 11:00:00 Equity Research | GRANGEX AB: PEA confirms robust economics for Sydvaranger – mapping the road to financial close in H2’25

2025-01-20 08:00:00 Equity Research | PROLIGHT: SpinChip deal highlights the strategic importance and valuation potential of Prolight's solution

2024-12-03 13:30:00 Equity Research | PROLIGHT: Commercial prototype marks an important milestone towards upcoming studies

2024-11-29 10:30:00 Equity Research | Nanexa AB: Phase I results position NEX-22 for licensing opportunities and a head start in long-acting GLP-1

2024-11-28 08:00:00 Equity Research | PROLIGHT: Advancing with strengthened financials towards clinical performance study in 2025

2024-11-08 08:00:00 Equity Research | Nanexa: Progress for rival at Novo illustrates the significant value potential in Nanexa

2024-11-04 08:00:00 Equity Research | CRUNCHFISH: Detailing the eight revenue opportunities ahead

2024-10-31 08:00:00 Equity Research | TALLINK: All about the Dividend

2024-10-11 09:00:00 CRUNCHFISH: Video | Vd Joachim Samuelsson om kommande emission och affärsmöjligheterna inom DC offline och CBDC

2024-09-23 08:00:00 Equity Research | CRUNCHFISH: Rights issue to stay the course on extended timeline

2024-09-09 08:00:00 Equity Research | GRANGEX: Emerging as Europe’s top DR concentrate developer

2024-08-30 09:00:00 Equity Research | MOTION DISPLAY: Strong gross margin driving another profitable quarter

2024-08-29 09:00:00 Equity Research | PROLIGHT: Pre-validation readout in Q4 sets stage for multicenter trial in 2025

2024-08-28 08:00:00 Nanexa AB: NEX-22 Progress, Revaluation and Financing

2024-08-26 08:00:00 Equity Research | CRUNCHFISH: Three avenues to address the strained financing

2024-08-19 11:00:00 Equity Research | Agtira AB: Big launch and a capital-light expansion in the cards

2024-06-17 12:00:00 Equity Research | GRANGEX: Updated DFS confirming viability to produce high-grade iron ore at Dannemora

2024-06-04 08:00:00 Equity Research | Free2Move Holding AB: Another step up the PropTech value chain

2024-05-20 10:30:00 Equity Research | Prolight Diagnostics: SEK 17m UK grant a welcome external validation

2024-05-16 08:00:00 Equity Research | FREE2MOVE: Slow start to 2025 but with a sharp uptick in early Q2

2024-05-15 10:00:00 Equity Research | Agtira: Mixed start to pivotal 2024

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Emergers

Prenumeration

Vem äger bolaget?

Emergers

Prenumeration

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden